Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
10/2000
10/17/2000US6133033 Method for in vitro selection of potato clones resistant to blackspot bruising and the potatoes produced therefrom
10/17/2000US6133030 Co-cultivation of cells in a micropatterned configuration
10/17/2000US6133029 Replication defective viral vectors for infecting human cells
10/17/2000US6133025 Nucleic acid for episomal replication in mammalian cells; includes a cis-acting origin of replication sequence and the nuclear antigen 1 sequence linked to a promoter; for gene therapy
10/17/2000US6133015 HHV-8+ lymphoma cell line which is HIV-, CMV-, EBV-, and which produces large amounts of uncontaminated HHV-8 virus
10/17/2000US6133007 Phosphodiesterase 8A
10/17/2000US6133006 Nucleotide sequence coding an enzmatic polypeptide associated with signal transduction; for the diagnosis and treatment of osteoporosis, inflammation, skin disorders, asthma, nervous system disorders, cancer, eating disorders and infections
10/17/2000US6132992 Expression vectors encoding bispecific fusion proteins and methods of producing biologically active bispecific fusion proteins in a mammalian cell
10/17/2000US6132987 Polypeptide associated with macrophages; for diagnosis and treatment of inflammation, arthritis and atherosclerosis
10/17/2000US6132983 Microorganismal protein with enzymatic activity associated with luminescence
10/17/2000US6132980 Antibodies specific for TRP-2 a human tumor antigen recognized by cytotoxic T lymphocytes
10/17/2000US6132979 Cytotoxicity testing method
10/17/2000US6132973 Nucleotide sequence coding protein associated with gene expression; for the diagnosis, prevention, and treatment of defects associated with cell proliferation
10/17/2000US6132966 Enzymatic nucleic acid which specifically prevents viral replication; for the treatment of transformed hepatocytes and suppression of viral infection humans, animals and primates
10/17/2000US6132962 Plasmid coding ribozyme; for the prevention of viral infection
10/17/2000US6132960 Envelope polypeptide; for the detection of plant parasite
10/17/2000US6132732 Parvovirus capsids
10/17/2000US6132728 Hedgehog-derived polypeptides
10/17/2000US6132718 Using a vaccine comprising antibodies and anti-idiotype antibodies that mimic an epitope of antigen that is associated with a tumor or infectious agent.
10/17/2000US6132713 Arginine deiminase derived from mycoplasma arthritidis and polymer conjugates containing the same
10/17/2000US6132708 Liver regeneration using pancreas cells
10/17/2000CA2117303C Anti-cancer immunotherapeutic vector constructs
10/17/2000CA1341123C Filamentous hemagglutinin of b. pertussis
10/17/2000CA1341119C Human erythroid-specific transcriptional enhancer
10/17/2000CA1341118C Nucleic acid and methods for the synthesis of novel decay accelerating factor compositions
10/17/2000CA1341117C Genetically engineered plant cells and plants exhibiting resistance to glutamine synthetase inhibitors, dna fragments and recombinants for use in the production of said cells and plants
10/12/2000WO2000060357A1 Tandem immuno-assay for cancer
10/12/2000WO2000060109A1 Amplification of cyp24 and uses thereof
10/12/2000WO2000060100A1 Dsp-9 dual-specificity map kinase phosphatase
10/12/2000WO2000060099A1 Dsp-4 dual-specificity map kinase phosphatase
10/12/2000WO2000060098A1 Dsp-7 dual-specificity map kinase phosphatase
10/12/2000WO2000060095A2 Enzymes of the biosynthetic pathway for the production of triacylglycerol and recombinant dna molecules encoding these enzymes
10/12/2000WO2000060090A1 Compounds and methods for the diagnosis and treatment of b. microti infection
10/12/2000WO2000060086A1 Pathogen inducible promoter
10/12/2000WO2000060082A2 Vesicle associated proteins
10/12/2000WO2000060080A2 Molecules of the immune system
10/12/2000WO2000060077A2 Compounds for therapy and diagnosis of lung cancer and methods for their use
10/12/2000WO2000060076A2 Compositions for the treatment and diagnosis of breast cancer and methods for their use
10/12/2000WO2000060066A1 Protein-protein from s. cerevisiae and methods of using same
10/12/2000WO2000060063A1 Lipase variant
10/12/2000WO2000060061A2 Transgenic plant resistant to mycotoxins and methods
10/12/2000WO2000060060A2 Polypeptides having alkaline alpha-amylase activity and nucleic acids encoding same
10/12/2000WO2000060059A2 Alpha-amylase variants
10/12/2000WO2000060058A2 Polypeptides having alkaline alpha-amylase activity and nucleic acids encoding same
10/12/2000WO2000060055A1 Modified dendritic cells and uses therefor
10/12/2000WO2000060054A1 Pharmaceutical compositions comprising circulating blood cells, preferably monocytes and uses thereof
10/12/2000WO2000060052A1 A method for altering the metabolism of plant
10/12/2000WO2000060051A2 Arpe-19 as a platform cell line for encapsulated cell-based delivery
10/12/2000WO2000060050A2 Recombinant influenza viruses for vaccines and gene therapy
10/12/2000WO2000059944A1 A monoclonal antibody against estrogen stimulated leucine aminopeptidase
10/12/2000WO2000059943A2 MONOCLONAL ANTIBODIES AGAINST HUMAN PROTEIN Mcm3, PROCESS FOR THEIR PRODUCTION, AND THEIR USE
10/12/2000WO2000059942A2 Human obesity protein binding protrein-2 homolog and uses thereof
10/12/2000WO2000059941A1 Purposeful movement of human migratory cells away from an agent source
10/12/2000WO2000059940A2 Platelet-derived growth factor related gene and protein
10/12/2000WO2000059936A1 Human neurogenin 3-encoding nucleotide sequences
10/12/2000WO2000059933A2 HUMAN MESENCHYMAL DNAs AND EXPRESSION PRODUCTS
10/12/2000WO2000059919A1 ANTISENSE MODULATION OF p38 MITOGEN ACTIVATED PROTEIN KINASE EXPRESSION
10/12/2000WO2000059916A1 Compounds selectively inhibiting gamma 9 delta 2 t lymphocytes
10/12/2000WO2000059618A1 Method for populating substrates with biological cells and populating devices that can be used therefor
10/12/2000WO2000059534A1 Method and compositions for preventing or reducing hiv infection by use of inhibitors for leucine aminopeptidase
10/12/2000WO2000059525A2 USE OF ErbB RECEPTOR LIGANDS IN TREATING DIABETES
10/12/2000WO2000059515A2 Immunomodulating polymers
10/12/2000WO2000037494A3 Chlamydia trachomatis antigens
10/12/2000WO2000036129A8 Enhanced protein production in higher plants by n-terminal fusion of a ubiquitin or a cucumber mosaic virus coat protein peptide
10/12/2000WO2000034491A3 An improved efficiency agrobacterium-mediated plant transformation method
10/12/2000WO2000028058A3 Transcriptional activator lec1 nucleic acids, polypeptides and their uses
10/12/2000WO2000025722A3 ENHANCED VACCINES COMPRISING SELF AND NON-SELF IgE PORTIONS OR DIMERIC ANTIGENS
10/12/2000WO2000023594A9 BIOACTIVE PEPTIDES AND PEPTIDE DERIVATIVES OF PARATHYROID HORMONE (PTH) AND PARATHYROID HORMONE-RELATED PEPTIDE (PTHrP)
10/12/2000WO2000020587A3 Cancer associated antigens and uses therefor
10/12/2000WO2000017322A9 Electroactive materials for stimulation of biological activity of cells
10/12/2000WO2000017232A3 Regulatory protein from human keratinocytes
10/12/2000WO2000015790A9 Leptin induced genes
10/12/2000WO1999064594A9 Genes and gene expression products that are differentially regulated in prostate cancer
10/12/2000WO1999058659A9 Methods and compositions for expression of transgenes in plants
10/12/2000WO1999057246A8 Animal cell culture media comprising non-animal or plant-derived nutrients
10/12/2000WO1999041376A8 Retinoblastoma protein complexes and retinoblastoma interacting proteins
10/12/2000WO1997036919A3 Cytokine designated lerk-8
10/12/2000DE19916140A1 Carotinhydroxylase und Verfahren zur Herstellung von Xanthophyllderivaten Carotene hydroxylase and method of producing Xanthophyllderivaten
10/12/2000DE10004815A1 Human sodium-phosphate cotransporter Npt2B, useful e.g. for identifying agents for treating hyper- and hypo-phosphatemia, and related nucleic acid
10/12/2000CA2368017A1 Use of erbb receptor ligands in treating diabetes
10/12/2000CA2367403A1 Dsp-9 dual-specificity map kinase phosphatase
10/12/2000CA2367378A1 Molecules of the immune system
10/12/2000CA2367109A1 Dsp-4 dual-specificity map kinase phosphatase
10/12/2000CA2367104A1 Dsp-7 dual-specificity map kinase phosphatase
10/12/2000CA2366895A1 Immunomodulating polymers
10/12/2000CA2365961A1 Human neurogenin 3-encoding nucleotide sequences
10/12/2000CA2365548A1 Protein-protein from s. cerevisiae and methods of using same
10/12/2000CA2365526A1 Recombinant influenza viruses for vaccines and gene therapy
10/12/2000CA2365438A1 Alpha-amylase variants
10/12/2000CA2365421A1 Vesicle associated proteins
10/12/2000CA2365413A1 Pathogen inducible promoter
10/12/2000CA2365221A1 Compositions for the treatment and diagnosis of breast cancer and methods for their use
10/12/2000CA2365040A1 Hob-bp2h compositions, methods and uses thereof
10/12/2000CA2303702A1 Growth hormone and growth hormone releasing hormone compositions
10/11/2000EP1043399A2 Hepatitis C Virus cell culture system
10/11/2000EP1043335A1 Monoclonal antibody against connective tissue growth factor and medicinal uses thereof
10/11/2000EP1043333A1 NOVEL POLYPEPTIDES, cDNAS ENCODING THE SAME AND UTILIZATION THEREOF
10/11/2000EP1042674A1 148 human secreted proteins
10/11/2000EP1042498A1 A method of finding agonist and antagonist to human 11cb splice variant
10/11/2000EP1042494A1 Adeno-associated virus and adenovirus chimeric recombinant viruses useful for the integration of foreign genetic information into the chromosomal dna of target cells